Soni Medicare Limited carries a market capitalization of 299.40M, placing it among publicly traded companies globally. Its enterprise value stands at 407.37M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 299.40M |
| Enterprise Value | 407.37M |
Soni Medicare Limited currently has 4.26M shares outstanding.
| Shares Outstanding | 4.26M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Soni Medicare Limited trades at a trailing price-to-earnings ratio of 52.96. The price-to-sales ratio is 1.22, and the price-to-book ratio stands at 7.06.
| PE Ratio | 52.96 |
| PS Ratio | 1.22 |
| PB Ratio | 7.06 |
| P/TBV Ratio | -19.87 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, Soni Medicare Limited trades at an EV/EBITDA multiple of 160.49 and an EV/FCF ratio of 32.71. The EV/Sales ratio of 1.65 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 160.49 provides insight into valuation relative to core operating earnings.
| EV / Sales | 1.65 |
| EV / EBITDA | 160.49 |
| EV / EBIT | 160.49 |
| EV / FCF | 32.71 |
Soni Medicare Limited maintains a current ratio of 1.13, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -1,049.31, indicating conservative leverage, while an interest coverage ratio of -1.17 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.13 |
| Quick Ratio | 0.15 |
| Debt / Equity | -1,049.31 |
| Debt / EBITDA | -9.08 |
| Interest Coverage | -1.17 |
| Return on Equity (ROE) | -97.51 |
| Return on Assets (ROA) | -11.09 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 7.85 |
| Income Tax | 644,000.00 |
| Effective Tax Rate | N/A |
Soni Medicare Limited's stock has gained approximately 24.31379% over the past 52 weeks. The 50-day moving average sits at 71.92, while the 200-day moving average is 85.78.
| Beta (5Y) | N/A |
| 52-Week Price Change | 24.31379% |
| 50-Day Moving Average | 71.92 |
| 200-Day Moving Average | 85.78 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Soni Medicare Limited generated 247.08M in revenue and converted that into -27.08M in net income, yielding earnings per share of -6.32. EBITDA reached -14.25M, while operating income came in at -14.25M.
| Revenue | 247.08M |
| Gross Profit | 178.96M |
| Operating Income | -14.25M |
| Pretax Income | -26.41M |
| Net Income | -27.08M |
| EBITDA | -14.25M |
| EBIT | -14.25M |
| Earnings Per Share (EPS) | -6.32 |
Soni Medicare Limited holds 23.20M in cash and equivalents against 129.47M in total debt, resulting in a net debt position of 110.59M. Total book value stands at 42.65M, with working capital of 19.69M providing operational flexibility.
| Cash & Cash Equivalents | 23.20M |
| Total Debt | 129.47M |
| Net Debt | 110.59M |
| Equity (Book Value) | 42.65M |
| Book Value Per Share | 9.95 |
| Working Capital | 19.69M |
Soni Medicare Limited operates with a gross margin of 72.43, reflecting its pricing power and cost economics. The operating margin of -5.77 and net profit margin of -10.96 provide insight into operational efficiency.
| Gross Margin | 72.43 |
| Operating Margin | -5.77 |
| Pretax Margin | -10.69 |
| Profit Margin | -10.96 |
| EBITDA Margin | -5.77 |
Soni Medicare Limited posts an Altman Z-Score of 1.49, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 1.49 |